Dimitrios C. Mastellos

9.6k total citations · 2 hit papers
76 papers, 6.8k citations indexed

About

Dimitrios C. Mastellos is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Dimitrios C. Mastellos has authored 76 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Immunology, 10 papers in Infectious Diseases and 9 papers in Molecular Biology. Recurrent topics in Dimitrios C. Mastellos's work include Complement system in diseases (49 papers), Renal Diseases and Glomerulopathies (9 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Dimitrios C. Mastellos is often cited by papers focused on Complement system in diseases (49 papers), Renal Diseases and Glomerulopathies (9 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Dimitrios C. Mastellos collaborates with scholars based in United States, Greece and Switzerland. Dimitrios C. Mastellos's co-authors include John D. Lambris, Daniel Ricklin, Edimara S. Reis, George Hajishengallis, Despina Yancopoulou, Antonio M. Risitano, Markus Huber‐Lang, Maciej M. Markiewski, Christoph W. Strey and Silvia Franchini and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Blood.

In The Last Decade

Dimitrios C. Mastellos

75 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis

2020 545 citations Panagiotis Skendros, Dimitrios C. Mastellos et al. Journal of Clinical Investigation profile →
A guide to complement biology, pathology and therapeutic opportunity

2023 135 citations Dimitrios C. Mastellos, George Hajishengallis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dimitrios C. Mastellos United States	40	4.0k	1.2k	1.2k	935	893	76	6.8k
Claudia Kemper United States	48	5.2k 1.3×	1.5k 1.2×	739 0.6×	627 0.7×	970 1.1×	136	7.9k
Gilles Kaplanski France	34	2.5k 0.6×	1.9k 1.6×	632 0.5×	994 1.1×	792 0.9×	145	6.4k
John Atkinson United States	59	5.2k 1.3×	2.1k 1.7×	1.2k 1.0×	1.3k 1.4×	1.6k 1.8×	160	9.6k
Wilhelm Schwaeble United Kingdom	53	5.8k 1.4×	1.4k 1.1×	611 0.5×	1.4k 1.4×	1.2k 1.4×	157	8.0k
Rick A. Wetsel United States	51	5.3k 1.3×	1.8k 1.5×	546 0.5×	1.4k 1.5×	863 1.0×	126	8.9k
Jörg Köhl Germany	59	6.4k 1.6×	2.4k 1.9×	659 0.6×	855 0.9×	1.2k 1.3×	197	10.8k
Francesco Tedesco Italy	53	5.4k 1.4×	1.4k 1.2×	568 0.5×	1.9k 2.0×	523 0.6×	190	9.3k
Anja Roos Netherlands	41	4.3k 1.1×	1.4k 1.1×	599 0.5×	941 1.0×	503 0.6×	74	6.6k
Leendert A. Trouw Netherlands	55	4.7k 1.2×	1.5k 1.2×	362 0.3×	1.2k 1.3×	493 0.6×	218	9.8k
Andreas Klos Germany	36	3.2k 0.8×	1.3k 1.1×	419 0.3×	624 0.7×	885 1.0×	114	5.3k

Countries citing papers authored by Dimitrios C. Mastellos

Since Specialization

Citations

This map shows the geographic impact of Dimitrios C. Mastellos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitrios C. Mastellos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitrios C. Mastellos more than expected).

Fields of papers citing papers by Dimitrios C. Mastellos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitrios C. Mastellos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitrios C. Mastellos. The network helps show where Dimitrios C. Mastellos may publish in the future.

Co-authorship network of co-authors of Dimitrios C. Mastellos

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitrios C. Mastellos. A scholar is included among the top collaborators of Dimitrios C. Mastellos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitrios C. Mastellos. Dimitrios C. Mastellos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kiritsis, Christos, Dimitrios C. Mastellos, Aristeidis Chiotellis, et al.. (2024). Synthesis and Evaluation of 99mTc(CO)3 Complexes with Ciprofloxacin Dithiocarbamate for Infection Imaging. Pharmaceutics. 16(9). 1210–1210. 1 indexed citations

Tripathy, Abinash, et al.. (2023). A High-Performance Antibacterial Nanostructured ZnO Microfluidic Device for Controlled Bacterial Lysis and DNA Release. Antibiotics. 12(8). 1276–1276. 2 indexed citations

Wang, Hui, et al.. (2022). Complement Is Required for Microbe-Driven Induction of Th17 and Periodontitis. The Journal of Immunology. 209(7). 1370–1378. 13 indexed citations

Lamers, Christina, Dimitrios C. Mastellos, Daniel Ricklin, & John D. Lambris. (2022). Compstatins: the dawn of clinical C3-targeted complement inhibition. Trends in Pharmacological Sciences. 43(8). 629–640. 45 indexed citations

Kaprou, Georgia D., et al.. (2021). Isothermal Recombinase Polymerase Amplification (RPA) of E. coli gDNA in Commercially Fabricated PCB-Based Microfluidic Platforms. Micromachines. 12(11). 1387–1387. 13 indexed citations

Kim, Benjamin J., Dimitrios C. Mastellos, Yafeng Li, Joshua L. Dunaief, & John D. Lambris. (2020). Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions. Progress in Retinal and Eye Research. 83. 100936–100936. 58 indexed citations

Mastellos, Dimitrios C., Panagiotis Skendros, Rodrigo T. Calado, Antonio M. Risitano, & John D. Lambris. (2020). Efficacy matters: broadening complement inhibition in COVID-19. The Lancet Rheumatology. 3(2). e95–e95. 2 indexed citations

Hughes, Sarah, Rebecca Lee, Avneesh Gautam, et al.. (2020). Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primates. Clinical Immunology. 214. 108391–108391. 17 indexed citations

Hajishengallis, George, Edimara S. Reis, Dimitrios C. Mastellos, Daniel Ricklin, & John D. Lambris. (2017). Novel mechanisms and functions of complement. Nature Immunology. 18(12). 1288–1298. 350 indexed citations

10.

Mastellos, Dimitrios C., Despina Yancopoulou, Petros Kokkinos, et al.. (2015). Compstatin: a C3‐targeted complement inhibitor reaching its prime for bedside intervention. European Journal of Clinical Investigation. 45(4). 423–440. 170 indexed citations

11.

Ritis, Konstantinos, Michael Doumas, Dimitrios C. Mastellos, et al.. (2006). A Novel C5a Receptor-Tissue Factor Cross-Talk in Neutrophils Links Innate Immunity to Coagulation Pathways. The Journal of Immunology. 177(7). 4794–4802. 378 indexed citations

12.

Kim, Alfred H.J., Ioannis D. Dimitriou, M. Claire Holland, et al.. (2004). Complement C5a Receptor Is Essential for the Optimal Generation of Antiviral CD8+ T Cell Responses. The Journal of Immunology. 173(4). 2524–2529. 86 indexed citations

13.

Markiewski, Maciej M., Dimitrios C. Mastellos, Ruxandra Tudoran, et al.. (2004). C3a and C3b Activation Products of the Third Component of Complement (C3) Are Critical for Normal Liver Recovery after Toxic Injury. The Journal of Immunology. 173(2). 747–754. 148 indexed citations

14.

Mastellos, Dimitrios C.. (2004). Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays. Molecular Immunology. 40(16). 1213–1221. 52 indexed citations

15.

Strey, Christoph W., Maciej M. Markiewski, Dimitrios C. Mastellos, et al.. (2003). The Proinflammatory Mediators C3a and C5a Are Essential for Liver Regeneration. The Journal of Experimental Medicine. 198(6). 913–923. 346 indexed citations

16.

Riedemann, Niels C., Renfeng Guo, Thomas A. Neff, et al.. (2002). Increased C5a receptor expression in sepsis. Journal of Clinical Investigation. 110(1). 101–108. 18 indexed citations

17.

Riedemann, Niels C., Ren-Feng Guo, Thomas A. Neff, et al.. (2002). Increased C5a receptor expression in sepsis. Journal of Clinical Investigation. 110(1). 101–108. 151 indexed citations

18.

Mastellos, Dimitrios C. & John D. Lambris. (2002). Complement: more than a ‘guard’ against invading pathogens?. Trends in Immunology. 23(10). 485–491. 124 indexed citations

19.

Mastellos, Dimitrios C., John C. Papadimitriou, Silvia Franchini, Panagiotis A. Tsonis, & John D. Lambris. (2001). A Novel Role of Complement: Mice Deficient in the Fifth Component of Complement (C5) Exhibit Impaired Liver Regeneration. The Journal of Immunology. 166(4). 2479–2486. 204 indexed citations

20.

Zarkadis, Ioannis K., Dimitrios C. Mastellos, & John D. Lambris. (2001). Phylogenetic aspects of the complement system. Developmental & Comparative Immunology. 25(8-9). 745–762. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact